Marshall Wace LLP Has $3.89 Million Stake in Xylem Inc. (NYSE:XYL)

Marshall Wace LLP reduced its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 54.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 33,510 shares of the industrial products company's stock after selling 40,039 shares during the period. Marshall Wace LLP's holdings in Xylem were worth $3,888,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Dempze Nancy E increased its position in shares of Xylem by 0.3% in the fourth quarter. Dempze Nancy E now owns 25,761 shares of the industrial products company's stock worth $2,989,000 after acquiring an additional 88 shares in the last quarter. Townsquare Capital LLC raised its holdings in Xylem by 0.8% during the fourth quarter. Townsquare Capital LLC now owns 11,074 shares of the industrial products company's stock valued at $1,285,000 after buying an additional 88 shares in the last quarter. Clear Creek Financial Management LLC raised its stake in shares of Xylem by 4.3% in the 4th quarter. Clear Creek Financial Management LLC now owns 2,315 shares of the industrial products company's stock valued at $269,000 after acquiring an additional 96 shares in the last quarter. Bleakley Financial Group LLC lifted its stake in shares of Xylem by 2.3% in the fourth quarter. Bleakley Financial Group LLC now owns 4,359 shares of the industrial products company's stock worth $506,000 after buying an additional 96 shares during the last quarter. Finally, U.S. Capital Wealth Advisors LLC lifted its position in Xylem by 1.3% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 7,868 shares of the industrial products company's stock worth $913,000 after acquiring an additional 98 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors.

Xylem Trading Up 0.5 %

NYSE XYL traded up $0.65 during trading hours on Thursday, hitting $121.22. The company's stock had a trading volume of 356,470 shares, compared to its average volume of 1,416,096. The stock has a fifty day moving average of $118.25 and a 200 day moving average of $122.16. The company has a quick ratio of 1.33, a current ratio of 1.76 and a debt-to-equity ratio of 0.19. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $146.08. The firm has a market capitalization of $29.50 billion, a P/E ratio of 33.16, a PEG ratio of 2.33 and a beta of 1.08.

Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $0.95 by $0.08. The company had revenue of $2.07 billion during the quarter, compared to analysts' expectations of $2.04 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. Xylem's revenue was up 1.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.90 EPS. Equities research analysts forecast that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Stockholders of record on Tuesday, February 18th were given a dividend of $0.40 per share. The ex-dividend date was Tuesday, February 18th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.32%. This is a positive change from Xylem's previous quarterly dividend of $0.36. Xylem's dividend payout ratio (DPR) is currently 43.72%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. Robert W. Baird reduced their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research report on Wednesday. Stifel Nicolaus lifted their price objective on Xylem from $140.00 to $141.00 and gave the company a "buy" rating in a report on Wednesday. Royal Bank of Canada increased their target price on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday. Finally, Citigroup cut their price objective on Xylem from $152.00 to $134.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $145.56.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.